Impact of adjuvant mitotane on the clinical course of patients with adrenocortical cancer: Two years later [5]

Cancer

Volumn 78, Issue 7, 1996, Pages 1520-1521

  Kasperlik Zaluska, A A ^a   Migdalska, B M ^a   Makowska, A M ^a  

^a MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

17 HYDROXYCORTICOSTEROID; 17 OXOSTEROID; MITOTANE;

ADRENAL CORTEX CARCINOMA; ADULT; CANCER ADJUVANT THERAPY; CANCER GROWTH; CASE REPORT; DOSE RESPONSE; DRUG EFFICACY; FEMALE; HUMAN; LETTER; PRIORITY JOURNAL; RECURRENT CANCER;

ADRENAL CORTEX NEOPLASMS; ADRENOCORTICAL CARCINOMA; ADULT; CHEMOTHERAPY, ADJUVANT; FEMALE; FOLLOW-UP STUDIES; HUMANS; MITOTANE; NEOPLASM RECURRENCE, LOCAL;

EID: 0029839225     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19961001)78:7<1520::AID-CNCR26>3.0.CO;2-0     Document Type: Letter

References (0)